Stay updated on VX-880 in Type 1 Diabetes: Safety Clinical Trial
Sign up to get notified when there's something new on the VX-880 in Type 1 Diabetes: Safety Clinical Trial page.

Latest updates to the VX-880 in Type 1 Diabetes: Safety Clinical Trial page
- Check4 days agoChange DetectedThe study has increased its number of locations from 24 to 25, and a specific location in San Francisco, California, has been added. Additionally, the date of the study has been updated to March 2025.SummaryDifference2%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check40 days agoChange DetectedThe study has been updated to include 24 locations with the addition of Edinburgh, UK, and the revision has been updated to v2.14.2, while the previous revision and one location have been removed.SummaryDifference3%
- Check55 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check62 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.4%
Stay in the know with updates to VX-880 in Type 1 Diabetes: Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-880 in Type 1 Diabetes: Safety Clinical Trial page.